Haematology learning on-the-go, made by UK haematologists who know you're busy, tired, and possibly holding a sandwich. Whether you're commuting, tidying up, or too spent to open a book, we aim to deliver short episodes to fit into your daily grind. From blood basics to niche deep dives, there's something for students, specialists, and the haemo-curious. Most episodes are tightly scripted for a solo host, crafted to feel like a clear, helpful colleague talking it through. Designed to support evidence-based thinking habits that outlast outdated exam knowledge. New episodes most weeks.
War of the Cords: Optimising Graft-versus-Leukaemia in Double Cord Blood Transplantation
In double cord blood transplantation, one unit engrafts and the other is rejected—but the losing unit might be doing more than previously imagined. A 2025 Blood Advances study from the Eurocord–EBMT registry reveals how the immunological battle between cord units can be redirected against leukaemia, particularly when the patient and losing unit share the right HLA mismatches. In this episode, we unpack the elegant biology behind this unintended vaccine effect, explore the surprising lack of e...
26 Jul 2025
Deep Dive: Paediatric/AYA AML Transplant Decisions in the Molecular Era
Which children and young adults with acute myeloid leukaemia should receive transplant in first remission? This episode explores a landmark 2025 analysis from the Children's Oncology Group that revisits this longstanding question through a contemporary molecular lens. Huang and colleagues, publishing in the Journal of Clinical Oncology, analysed outcomes for over 1,400 patients from the AAML0531 and AAML1031 trials—studies that enrolled patients up to age 29. By retrospectively applying conte...
25 Jul 2025
Rapid Review: Paediatric/AYA AML Transplant Decisions in the Molecular Era
Which children and young adults with acute myeloid leukaemia should receive transplant in first remission? In this Rapid Review, we explore a landmark analysis by Huang et al., published in the Journal of Clinical Oncology in April 2025. Reclassifying over 1,400 patients using AAML1831 criteria, the study offers a contemporary perspective on who gains from transplant—and who doesn't. The results are compelling: disease-free survival doubles for most molecularly defined high-risk patients, whi...
20 Jul 2025
First-Line Ven/Aza/Revumenib for AML?
Could targeting the menin–KMT2A axis up front improve outcomes in older adults with NPM1-mutated or KMT2A-rearranged AML? In this episode, we examine new phase I data from Zeidner and colleagues, published in The Journal of Clinical Oncology in June 2025, investigating revumenib in combination with azacitidine and venetoclax for newly diagnosed patients ineligible for intensive therapy. We explore the shared biological mechanism linking these two subtypes, the rationale for adding menin inhib...
20 Jul 2025
Targeting Menin in Acute Leukaemia: AUGMENT-101 Results
Building on our earlier Biology Tangent episode on menin inhibition, this clinical deep-dive explores the pivotal AUGMENT-101 trial results that led to FDA approval of revumenib — the first licensed menin inhibitor for acute leukaemias. Revumenib has shown meaningful activity in relapsed or refractory KMT2A-rearranged and NPM1-mutated acute leukaemias, illustrating how targeting transcriptional dependencies can restore differentiation, even in heavily pretreated patients. We examine key effic...
19 Jul 2025
Mechanism to Medicine: Menin as Model
How does understanding normal blood cell development lead to breakthrough cancer therapies? This Biology Tangent episode explores the science behind menin inhibitors - therapies that act across age groups, lineages, and genetic subtypes by targeting shared developmental circuitry. We examine why both KMT2A-rearranged and NPM1-mutated leukaemias depend on this unexpected vulnerability, and how disrupting a single protein can unlock differentiation across multiple cancer types. From chromatin r...
17 Jul 2025
Bonus Episode: “What analyser does your lab use and why?” (a fair FRCPath question)
A deeper dive for haematology trainees and biomedical scientists. This bonus episode explores the technology behind specific modern full blood count analysers—including Sysmex, Beckman Coulter, Abbott, Siemens, and Roche—and why analyser choice matters clinically, diagnostically, and even in exams. Episode type: Core Haematology
14 Jul 2025
Reticulocytes, CHr, and IRF: The Most Useful Tests You’re Not Using?
The 2am anaemia admission. The four-year-old who’s "a bit tired" with a normal Hb and MCV. The anaemic dialysis patient with a mildly raised ferritin. In each case, reticulocyte parameters could change your clinical decision-making. Join us to explore how modern analysers reveal not just red cell quantity but quality, why CHr outperforms ferritin in detecting early iron deficiency, and how IRF predicts marrow recovery before counts improve. Depending on where you work, all of these tests may ...
12 Jul 2025
Of Clumps and Counts: Understanding Platelet Parameters
Platelets are minuscule, but they cause outsized trouble in the lab and the clinic. From EDTA clumping to cryoglobulin confusion, from giant platelets that escape detection to inherited disorders masquerading as ITP, we explore the curious twists behind every platelet parameter. Join us for a tour of the quirks and pitfalls of platelet counting, why the MPV misleads more than it helps, and how the immature platelet fraction might tell us something useful, if we know how to interpret it. In a ...
7 Jul 2025
Reading Between the Cells: Making Sense of WBC Differentials
Full blood counts: We all request thousands and glance at them every day. If there’s one test worth understanding inside out, it’s this one. This episode focuses on white cells: how modern analysers generate a differential count, why they throw up so many flags, and when you should pick up the phone. Learn how to interpret automated white cell differentials, when to insist on a blood film, and why a bit of technological insight might save you from the missed diagnosis—or the 3am emergency tha...
5 Jul 2025
Haemline Trailer
Haemline Trailer Welcome to Haemline, your companion for bite-sized haematology learning on the go. Whether you're commuting, doing the washing up, or simply too exhausted after a long shift to read anything, we aim to deliver focused haematology education to complement the excellent podcast resources already available. Created by practising UK haematologists, our scripts are carefully crafted to be conversational yet compact - the sort of resource we wish we'd had when starting out. Haemline...
3 Jul 2025
Understanding RBC Parameters: Patterns, Pitfalls, and Clinical Pearls
Red cells: they're not just bags of haemoglobin. In this episode of Haemline, we unlock the diagnostic goldmine hiding in those RBC parameters you've been scrolling past. Learn how to interpret red cell count, MCV, RDW, MCH, and MCHC in context - and why their relationships often matter more than the individual values. Featuring: cold agglutinins behaving badly, the rule of threes, and why your biomedical scientist deserves more credit. Through real clinical cases, we explore how to disentang...
30 Jun 2025
Dead Cells Tell Tales: How Pre-Analytical Pitfalls Shape the FBC
Welcome back to Haemline. This is episode two in our six-part series on the full blood count. You order it every day. You trust it—perhaps too much. You ignore parameters that might actually be useful. By the end of this series, we hope you'll never look at an FBC the same way again. In today's episode, "Dead Cells Tell Tales: How Pre-Analytical Pitfalls Shape the FBC," we'll explore how the journey from vein to laboratory shapes those numbers you rely on to guide your clinical decisions. Se...
30 Jun 2025
From Haemocytometers to AI: The FBC, Explained
Welcome to the first episode of Haemline, your companion for haematology learning on-the-go. Today marks the beginning of our six-part series on the full blood count – that ubiquitous test we order countless times each day. Over the coming episodes, we'll explore everything from pre-analytical pitfalls to the clinical insights hidden within those parameters you often ignore. In this first episode, "From Haemocytometers to AI: The FBC, Explained," we'll trace the evolution of blood counting f...
Podcast Authority Score: 23 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
46
Social presence
0
YouTube
0
Engagement
0
Contact Haemline
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Haemline?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
